Attenuating loss of cardiac conduction during no-flow ischemia through changes in perfusate sodium and calcium

Gregory S Hoeker1, Carissa C James1,2, Allison N Tegge3,4

  • 1Center for Heart and Reparative Medicine Research, Fralin Biomedical Research Institute at Virginia Tech Carilion, Roanoke, Virginia.

Insights

Altering perfusate sodium and calcium concentrations can protect the heart during ischemia. Increasing both ions widens the perinexus, preserving conduction and reducing arrhythmias.

Area of Science:

  • Cardiovascular Physiology
  • Cardiac Electrophysiology
  • Cellular Nanodynamics

Background:

  • Myocardial ischemia impairs cardiac electrical conduction, leading to arrhythmias.
  • Previous studies showed perfusate ion concentrations affect conduction during simulated ischemia.
  • The impact of perfusate composition on ischemic conduction and perinexus width during no-flow ischemia is unknown.

Purpose of the Study:

  • To investigate if altering preischemic perfusate sodium (Na+) and calcium (Ca2+) can widen the perinexus.
  • To determine if perinexal expansion attenuates conduction slowing during global no-flow ischemia.
  • To test the hypothesis that modified perfusate composition facilitates perinexal expansion and preserves ischemic conduction.

Main Methods:

  • Ex vivo guinea pig hearts (n=49) were Langendorff perfused.
  • Hearts were perfused with varying Na+ (145 or 153 mM) and Ca2+ (1.25 or 2.0 mM) concentrations.
  • Optical mapping was used to assess cardiac conduction during 30 minutes of no-flow ischemia.

Main Results:

  • Increasing extracellular Na+ and Ca2+ selectively widened the perinexus during ischemia (22.7 vs. 15.7 nm).
  • This widening significantly attenuated conduction slowing compared to reduced ion concentrations.
  • Neither repolarization nor connexin43 levels correlated with conduction slowing or block.

Conclusions:

  • Perfusate-dependent widening of the perinexus preserves ischemic conduction.
  • Altering extracellular ion concentrations can modulate ephaptic coupling to protect against ischemic stress.
  • Changes in ephaptic coupling may represent an adaptive response to acute myocardial ischemia.

Related Concept Videos

Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
5.0K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.2K
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
8.4K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.1K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.4K
Resting Potential Decay01:15

Resting Potential Decay

The resting membrane potential of a neuron (-70mV) is sustained due to the selective ion permeability of the membrane. At the resting potential, the membrane is slightly permeable to ions like sodium (Na+) and chloride (Cl−) and highly permeable to potassium ions (K+). Differences in the ions' concentration inside the cell compared to the outside are maintained by membrane transport proteins like channels and pumps.
At rest, the K+ is the main ion that moves across the membrane...
5.9K